Assembly Biosciences Statistics
Total Valuation
ASMB has a market cap or net worth of $571.21 million. The enterprise value is $340.47 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASMB has 15.56 million shares outstanding. The number of shares has increased by 51.02% in one year.
| Current Share Class | 15.56M |
| Shares Outstanding | 15.56M |
| Shares Change (YoY) | +51.02% |
| Shares Change (QoQ) | +65.70% |
| Owned by Insiders (%) | 3.89% |
| Owned by Institutions (%) | 9.94% |
| Float | 7.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.22 |
| Forward PS | n/a |
| PB Ratio | 3.08 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.44 |
| Quick Ratio | 4.37 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.94% and return on invested capital (ROIC) is -25.51%.
| Return on Equity (ROE) | -36.94% |
| Return on Assets (ROA) | -15.96% |
| Return on Invested Capital (ROIC) | -25.51% |
| Return on Capital Employed (ROCE) | -23.28% |
| Revenue Per Employee | $509,466 |
| Profits Per Employee | -$528,041 |
| Employee Count | 73 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -76,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +119.46% in the last 52 weeks. The beta is 1.17, so ASMB's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +119.46% |
| 50-Day Moving Average | 27.36 |
| 200-Day Moving Average | 18.43 |
| Relative Strength Index (RSI) | 76.35 |
| Average Volume (20 Days) | 122,365 |
Short Selling Information
The latest short interest is 1.29 million, so 8.29% of the outstanding shares have been sold short.
| Short Interest | 1.29M |
| Short Previous Month | 1.53M |
| Short % of Shares Out | 8.29% |
| Short % of Float | 17.70% |
| Short Ratio (days to cover) | 9.54 |
Income Statement
In the last 12 months, ASMB had revenue of $37.19 million and -$38.55 million in losses. Loss per share was -$4.48.
| Revenue | 37.19M |
| Gross Profit | -18.74M |
| Operating Income | -43.45M |
| Pretax Income | -38.62M |
| Net Income | -38.55M |
| EBITDA | -43.32M |
| EBIT | -43.45M |
| Loss Per Share | -$4.48 |
Full Income StatementBalance Sheet
The company has $232.56 million in cash and $2.76 million in debt, giving a net cash position of $229.80 million or $14.77 per share.
| Cash & Cash Equivalents | 232.56M |
| Total Debt | 2.76M |
| Net Cash | 229.80M |
| Net Cash Per Share | $14.77 |
| Equity (Book Value) | 182.70M |
| Book Value Per Share | 11.55 |
| Working Capital | 183.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$55.74 million and capital expenditures -$42,000, giving a free cash flow of -$55.78 million.
| Operating Cash Flow | -55.74M |
| Capital Expenditures | -42,000 |
| Free Cash Flow | -55.78M |
| FCF Per Share | -$3.58 |
Full Cash Flow StatementMargins
Gross margin is -50.39%, with operating and profit margins of -116.83% and -103.65%.
| Gross Margin | -50.39% |
| Operating Margin | -116.83% |
| Pretax Margin | -103.85% |
| Profit Margin | -103.65% |
| EBITDA Margin | -116.48% |
| EBIT Margin | -116.83% |
| FCF Margin | n/a |
Dividends & Yields
ASMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -51.02% |
| Shareholder Yield | -51.02% |
| Earnings Yield | -6.76% |
| FCF Yield | -9.78% |
Analyst Forecast
The average price target for ASMB is $44.25, which is 20.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.25 |
| Price Target Difference | 20.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 18.27% |
| EPS Growth Forecast (5Y) | -34.08% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 12, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 12, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
